We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$18.3B
AUM Growth
+$2.74B
(+18%)
Cap. Flow
+$2.65B
Cap. Flow
% of AUM
14.52%
Top 10 Holdings %
Top 10 Hldgs %
8.78%
Holding
1,974
New
365
Increased
607
Reduced
559
Closed
443
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 2 |
Honeywell
HON
|
+$158M |
| 3 |
Snap
SNAP
|
+$147M |
| 4 |
Citigroup
C
|
+$130M |
| 5 |
Mercado Libre
MELI
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$135M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$127M |
| 3 |
Verizon
VZ
|
+$121M |
| 4 |
Elevance Health
ELV
|
+$98.1M |
| 5 |
Abbott
ABT
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.4% |
| 2 | Consumer Discretionary | 13.55% |
| 3 | Industrials | 13.46% |
| 4 | Financials | 13.19% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
NovoCure
NVCR
$2.05B
| $3.49M | 0.02% |
+46,518
| New | +$4.67M |
|
|
COOP
852
DELISTED
Mr. Cooper
COOP
| $3.49M | 0.02% |
83,926
-33,886
| -29% | -$1.43M |
|
853
Sabre
SABR
$831M
| $3.49M | 0.02% |
406,202
-1,398,821
| -77% | -$13.4M |
|
|
CDMO
854
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.49M | 0.02% |
119,583
-36,760
| -24% | -$1.05M |
|
855
CNO Financial Group
CNO
$5.02B
| $3.48M | 0.02% |
146,201
+57,399
| +65% | +$1.41M |
|
856
Hormel Foods
HRL
$13.4B
| $3.48M | 0.02% |
71,301
-24,551
| -26% | -$1.08M |
|
857
VeriSign
VRSN
$25.6B
| $3.48M | 0.02% |
+13,700
| New | +$3.17M |
|
858
Amcor
AMCR
$21.5B
| $3.47M | 0.02% |
57,786
-8,106
| -12% | -$481K |
|
859
Mine Safety
MSA
$7.41B
| $3.45M | 0.02% |
22,878
-4,142
| -15% | -$622K |
|
860
Cogent Communications
CCOI
$525M
| $3.45M | 0.02% |
47,128
+30,158
| +178% | +$2.27M |
|
861
First Bancorp
FBP
$4.46B
| $3.45M | 0.02% |
250,291
+186,361
| +292% | +$2.56M |
|
862
Murphy USA
MUSA
$10.1B
| $3.45M | 0.02% |
17,305
-12,870
| -43% | -$2.3M |
|
|
VNE
863
DELISTED
Veoneer, Inc.
VNE
| $3.44M | 0.02% |
97,040
-104,415
| -52% | -$3.69M |
|
864
Astrana Health
ASTH
$1.78B
| $3.44M | 0.02% |
46,796
-86,663
| -65% | -$7.12M |
|
865
Vicor
VICR
$10.4B
| $3.43M | 0.02% |
26,992
+21,831
| +423% | +$3.09M |
|
|
ZY
866
DELISTED
Zymergen Inc. Common Stock
ZY
| $3.42M | 0.02% |
+510,920
| New | +$4.96M |
|
867
Enanta Pharmaceuticals
ENTA
$393M
| $3.4M | 0.02% |
45,483
+33,319
| +274% | +$2.61M |
|
|
UCTT
868
Ultra Clean Holdings
UCTT
$4.1B
| $3.39M | 0.02% |
59,083
-29,001
| -33% | -$1.51M |
|
869
Capri Holdings
CPRI
$1.77B
| $3.39M | 0.02% |
52,174
+35,899
| +221% | +$2.13M |
|
870
CF Industries
CF
$18.2B
| $3.38M | 0.02% |
47,824
-190,700
| -80% | -$11.9M |
|
871
Patterson-UTI
PTEN
$4.2B
| $3.37M | 0.02% |
399,323
+2,702
| +0.7% | +$23.3K |
|
|
EXAS
872
DELISTED
Exact Sciences
EXAS
| $3.37M | 0.02% |
+43,340
| New | +$3.82M |
|
873
Haemonetics
HAE
$4.16B
| $3.36M | 0.02% |
63,429
-49,501
| -44% | -$3.02M |
|
|
NVTA
874
DELISTED
Invitae Corporation
NVTA
| $3.36M | 0.02% |
220,321
+167,428
| +317% | +$3.62M |
|
875
Moelis & Co
MC
$4.91B
| $3.35M | 0.02% |
+53,556
| New | +$3.59M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2021 Portfolio in Review
As of Q4 2021, Voloridge Investment Management held 1,974 positions worth $18.3B, up 18% from $15.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management deployed $2.65B of net new capital in Q4 2021, opening 365 new positions and adding to 607 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 850,000 shares worth $404M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $135M trimmed.
- Voloridge Investment Management's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 850,000 shares worth $404M.
- Voloridge Investment Management added most to Honeywell in Q4 2021, an estimated $158M increase.
- Voloridge Investment Management's biggest Q4 2021 reduction was Micron Technology, cutting an estimated $135M.
- Voloridge Investment Management fully exited Abbott in Q4 2021, selling an estimated $89.9M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $18.3B portfolio in Q4 2021.
- Voloridge Investment Management opened 365 new positions and closed 443 in Q4 2021.
- Voloridge Investment Management's portfolio value rose 18% quarter-over-quarter to $18.3B.
Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.